Sex hormones, the anticancer immune response, and therapeutic opportunities

This publication has 141 references indexed in Scilit:

• Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer
  Cancer Cell, 2023
• Sex dimorphism and cancer immunotherapy: May pregnancy solve the puzzle?
  Cancer Treatment Reviews, 2023
• 1771MO Pembrolizumab (pembro) plus enzalutamide (enza) for patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Randomized double-blind phase III KEYNOTE-641 study
  Annals of Oncology, 2023
• Training the microbiota to increase immune checkpoint blockade and to reduce toxicity
  European Journal of Immunology, 2023
• Sex and cancer immunotherapy: Current understanding and challenges
  Cancer Cell, 2022
• Association of Obesity With Survival Outcomes in Patients With Cancer
  JAMA Network Open, 2021
• Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition
  Cell, 2021
• Clinical Pharmacokinetics and Pharmacodynamics of Immune Checkpoint Inhibitors
  Clinical Pharmacokinetics, 2019
• Estrogen receptors regulate innate immune cells and signaling pathways
  Cellular Immunology, 2015
• Androgen ablation augments prostate cancer vaccine immunogenicity only when applied after immunization
  The Prostate, 2009